The Global Microbial Polysaccharides for Pharmaceutical Market was valued at USD 825.7 Million in 2023 and is projected to reach USD 1.28 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period (2024–2030). This expansion is fueled by the increasing demand for high-quality excipients in novel drug formulations, the rising adoption of biopharmaceuticals, and the superior functional properties of microbial polysaccharides as stabilizers, viscosity enhancers, and controlled-release agents.

As the pharmaceutical industry pivots towards more sophisticated and effective drug delivery systems, microbial-derived polysaccharides are becoming indispensable. These naturally sourced polymers offer unparalleled biocompatibility and functionality. In this blog, we profile the Top 10 Companies in the Microbial Polysaccharides for Pharmaceutical Industry—a dynamic group of innovators, from established biochemical giants to specialized biotech firms, shaping the future of pharmaceutical science.

Download FREE Sample Report:
Global Microbial Polysaccharides for Pharmaceutical Market – View in Detailed Research Report

---

🔟 1. CP Kelco

Headquarters: Atlanta, Georgia, USA
Key Offering: Gellan Gum (Kelcogel®), Xanthan Gum

CP Kelco is a leading global producer of nature-based ingredient solutions, with a strong portfolio of microbial polysaccharides tailored for pharmaceutical applications. Their high-purity Gellan Gum is widely used as a gelling, suspending, and stabilizing agent in liquid and semi-solid formulations.

Innovation Initiatives:

• Investment in high-purity, pharmaceutical-grade fermentation processes

• Development of customized polysaccharide solutions for controlled drug release

• Focus on sustainable and traceable sourcing for regulatory compliance

---

9️⃣ 2. Deosen Biochemical Ltd.

Headquarters: Shandong, China
Key Offering: Hyaluronic Acid, Xanthan Gum, Gellan Gum

Deosen Biochemical is a major manufacturer of fermentation-derived polysaccharides, supplying high-quality ingredients to the global pharmaceutical market. The company has significant production capacity and a strong focus on research and development for novel applications.

Innovation Initiatives:

• Expansion of production facilities to meet growing global demand

• R&D into new microbial strains for enhanced polysaccharide yields and properties

---

8️⃣ 3. Jungbunzlauer Suisse AG

Headquarters: Basel, Switzerland
Key Offering: Xanthan Gum (Xanthan Gum Jungbunzlauer)

Jungbunzlauer is a renowned producer of biodegradable ingredients of natural origin. Their pharmaceutical-grade Xanthan Gum is known for its consistent quality and is used as a thickener, stabilizer, and emulsifier in a variety of drug formulations, including syrups and suspensions.

Innovation Initiatives:

• Commitment to sustainable production using renewable raw materials

• Stringent quality control systems ensuring compliance with global pharmacopoeias (USP, EP, JP)

---

7️⃣ 4. Pharmacosmos A/S

Headquarters: Holbaek, Denmark
Key Offering: Dextran derivatives, Iron Carbohydrate complexes

Pharmacosmos is a specialized pharmaceutical company with expertise in carbohydrates, particularly Dextran and its derivatives. These polysaccharides are critical in various medical applications, including as plasma volume expanders and as carriers for iron in parenteral formulations.

Innovation Initiatives:

• Pioneering research in carbohydrate chemistry for therapeutic applications

• Development of novel iron-carbohydrate drugs for anemia treatment

Download FREE Sample Report:
Global Microbial Polysaccharides for Pharmaceutical Market – View in Detailed Research Report

---

6️⃣ 5. Hayashibara Co., Ltd.

Headquarters: Okayama, Japan
Key Offering: Pullulan, Trehalose

Hayashibara is a Japanese biotech leader famous for its innovative carbohydrate products. Their high-purity Pullulan, a polysaccharide produced by *Aureobasidium pullulans*, is used in pharmaceutical coatings, capsule formulations, and as a film-forming agent.

Innovation Initiatives:

• Extensive application development for Pullulan in nutraceutical and pharmaceutical films

• Focus on clean-label, non-animal-derived excipients

---

5️⃣ 6. Meito Sangyo Co., Ltd.

Headquarters: Nagoya, Japan
Key Offering: Dextran, Sucrose Fatty Acid Esters

Meito Sangyo has a long history of producing fine chemicals and polysaccharides. The company supplies various molecular weights of Dextran, which are essential for research, diagnostics, and as excipients in pharmaceutical products requiring specific viscosity or molecular carrier properties.

Innovation Initiatives:

• Specialization in fractionated Dextrans for specific research and medical uses

• Quality-focused manufacturing adhering to international standards

---

4️⃣ 7. Shandong Jinyang Pharmaceutical Co., Ltd.

Headquarters: Shandong, China
Key Offering: Xanthan Gum, Pharmaceutical Intermediates

Shandong Jinyang Pharmaceutical is a significant Chinese manufacturer of pharmaceutical ingredients, including microbial polysaccharides. The company produces Xanthan Gum that meets pharmacopeial requirements for use as a stabilizer and suspending agent in liquid oral dosage forms.

Innovation Initiatives:

• Capacity expansion to solidify its position in the global supply chain

• Investment in R&D to improve fermentation efficiency and product purity

---

3️⃣ 8. Polydex Pharmaceuticals Limited

Headquarters: Toronto, Canada
Key Offering: Dextran, Specialty Chemicals

Polydex Pharmaceuticals is engaged in the development and manufacture of bulk pharmaceutical ingredients, with Dextran being a key product. The company serves the pharmaceutical industry with products used in a range of applications from tablet binding to specialized medical uses.

Innovation Initiatives:

• Strategic focus on niche pharmaceutical applications for Dextran polymers

• Collaborations with research institutions for new product development

---

2️⃣ 9. Lushang Freda Pharmaceutical Co., Ltd.

Headquarters: Shandong, China
Key Offering: Xanthan Gum, Starch Derivatives

Lushang Freda Pharmaceutical is a diversified pharmaceutical company with a strong foothold in the excipients market. Its microbial polysaccharide offerings are integral to its portfolio, catering to both domestic and international pharmaceutical manufacturers.

Innovation Initiatives:

• Vertical integration from raw material to finished excipient

• Focus on cost-effective production without compromising on quality standards

---

1️⃣ 10. Shandong Kangnaxin Biotechnology Co., Ltd.

Headquarters: Shandong, China
Key Offering: Xanthan Gum, Gellan Gum

Shandong Kangnaxin Biotechnology specializes in the fermentation and production of biopolymers. As an emerging player, the company is increasing its market share by supplying competitively priced, high-quality microbial polysaccharides to the pharmaceutical sector.

Innovation Initiatives:

• Rapid scaling of production capabilities to meet export demand

• Investment in quality assurance systems to gain international certifications

Get Full Report Here:
Global Microbial Polysaccharides for Pharmaceutical Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Microbial Polysaccharides Is Smart and Targeted

The microbial polysaccharides market is undergoing a significant transformation. While traditional applications in stabilization and viscosity remain vital, the industry is increasingly focused on advanced drug delivery systems, personalized medicine, and the development of novel biotherapeutic formulations.

📈 Key Trends Shaping the Market:

• Growing demand for plant-based and non-animal-derived pharmaceutical excipients

• R&D into polysaccharide-based hydrogels for controlled and targeted drug release

• Increasing use in biologics and complex injectables requiring superior stabilization

• Expansion of regulatory filings (DMFs, CEPs) for pharmaceutical-grade polysaccharides

Get Full Report Here:
Global Microbial Polysaccharides for Pharmaceutical Market – View in Detailed Research Report

The companies profiled above are not merely suppliers of ingredients; they are essential partners in advancing pharmaceutical science, enabling the development of safer, more effective, and more sophisticated medicines for patients worldwide.